Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$25.57+1.34 (+5.53%)
Close on Nov 18, 2026Market cap $2.06BP/E 18.3Yield –
Veracyte market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Veracyte's market cap was $2.02B on Nov 11, 2026, against $3.74B a year earlier. Over the last 5 years it ranged from $1.19B to $4.69B, with a median of $2.01B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.02B | -39.4% |
| 2025 | Dec 31, 2025 | $3.33B | +8.4% |
| 2024 | Dec 31, 2024 | $3.07B | +52.8% |
| 2023 | Dec 29, 2023 | $2.01B | +18.0% |
| 2022 | Dec 30, 2022 | $1.70B | -41.8% |
| 2021 | Dec 31, 2021 | $2.93B | +3.4% |
| 2020 | Dec 31, 2020 | $2.83B | +107.6% |
| 2019 | Dec 31, 2019 | $1.36B | +167.3% |
| 2018 | Dec 31, 2018 | $509.94M | +129.8% |
| 2017 | Dec 29, 2017 | $221.88M | +2.6% |
| 2016 | Dec 30, 2016 | $216.26M | +8.6% |
| 2015 | Dec 31, 2015 | $199.13M | -8.3% |
| 2014 | Dec 31, 2014 | $217.26M | +1409.5% |
| 2013 | Dec 31, 2013 | $14.39M | – |
See a number that looks wrong?